American Academy of Family Physicians
Home Page > CME Center > Self-Study CME > CME Bulletin > Alzheimer's Disease: New Research and Treatment Indications for Family Physicians > Read the Bulletin > References

Search  

Advanced Search

References


  1. National Center for Health Statistics. Alzheimer’s Disease. CDC Fast Stats. Available at http://www.cdc.gov/nchs/fastats/alzheimr.htm.
  2. Alzheimer’s Association. 2010 Alzheimer’s disease facts and figures. Available at http://www.alz.org/documents_custom/report_alzfactsfigures2010.pdf.
  3. Querfurth HW, LaFerla FM. Alzheimer’s disease. N Engl J Med. 2010;362(4):329-344 [Review].
  4. Carter MD, Simms GA, Weaver DF. The development of new therapeutics for Alzheimer’s disease. Clin Pharmacol Ther. 2010;88(4):475-486 [Review].
  5. Kamat SM, Kamat AS, Grossberg GT. Dementia risk prediction: are we there yet? Clin Geriatr Med. 2010;26(1):113-123 [Review].
  6. Alzheimer’s Disease Education & Referral (ADEAR) Center. Alzheimer’s disease genetics fact sheet. NIH Publication No. 08-6424; 2008.
  7. Han W, Li C. Linking type 2 diabetes and Alzheimer’s disease. Proc Natl Acad Sci U S A. 2010;107(15):6557-6558.
  8. Flicker L. Modifiable lifestyle risk factors for Alzheimer’s disease. J Alzheimers Dis. 2010;20(3):803-811 [Review].
  9. Féart C, Samieri C, Barberger-Gateau P. Mediterranean diet and cognitive function in older adults. Curr Opin Clin Nutr Metab Care. 2010;13(1):14-18 [Review].
  10. Raffaitin C, Féart C, Le Goff M, et al. Metabolic syndrome and cognitive decline in French elders: the Three-City Study. Neurology. 2011;76(6):518-525.
  11. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR). Washington, DC: 2000.
  12. Salloway S, Correia S. Alzheimer disease: time to improve its diagnosis and treatment. Cleve Clin J Med. 2009;76(1):49-58 [Review].
  13. Iliffe S, Robinson L, Brayne C, et al. Primary care and dementia: 1. diagnosis, screening and disclosure. Int J Geriatr Psychiatry. 2009;24(9):895-901 [Review].
  14. Villars H, Oustric S, Andrieu S, et al. The primary care physician and Alzheimer’s disease: an international position paper. J Nutr Health Aging. 2010;14(2):110-120.
  15. Rosack J. New diagnostic test may improve dementia care. Psychiatric News. 2006;41(23):24. Also available at http://pn.psychiatryonline.org/content/41/23/24.full.
  16. Nasreddine ZS, Phillips NA, Bédirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695-699.
  17. Milne A, Culverwell A, Guss R, et al. Screening for dementia in primary care: a review of the use, efficacy and quality of measure. Int Psychogeriatr. 2008;20(5):911-926 [Review].
  18. De Souza LC, Sarazin M, Goetz C, et al. Clinical investigations in primary care. Front Neurol Neurosci. 2009;24:1-11 [Review].
  19. Sperling RA, Aisen PS, Beckett LA, et al. Toward defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute on Aging and the Alzheimer’s Association workgroup. Alzheimers Dement. 2011. Available at http://www.alz.org/documents_custom/Diagnostic_Recommendations_Alz_Preclinical.pdf.
  20. Jack CR, Albert MS, Knopman DS, et al. Introduction to the recommendations from the National Institute on Aging and the Alzheimer’s Association workgroup on diagnostic guidelines for Alzheimer’s disease. 2011. Available at http://www.alz.org/documents_custom/Intro_Diagnostic_Recommendations_Alz_proof.pdf
  21. Carr DB, Ott BR. The older adult driver with cognitive impairment: “It’s a very frustrating life”. JAMA. 2010;303(16):1632-1641. Erratum in JAMA. 2010;303(23):2357.
  22. Hunsaker AE, Schmidt K, Lingler JH. Discussing dementia-related behaviors during medical visits for people with Alzheimer’s disease. Am J Alzheimers Dis Other Demen. 2010;25(3):248-254.
  23. Dubinsky RM. Practice parameter: risk of driving and Alzheimer’s disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2000;54(12)2205-2211 [Review].
  24. Iverson DJ. Practice parameter update: evaluation and management of driving risk in dementia: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2010;74(16):1316-1324 [Review].
  25. Miller B, McFall S. Caregiver burden and institutionalization, hospital use, and stability of care: final report for the Office of the Assistant Secretary for Planning and Evaluation, US Department of Health and Human Services. 1989.
  26. Dang S, Basdiye A, Kelkar G. The dementia caregiver – a primary care approach. South Med J. 2008;101(12):1246-1251.
  27. Daviglus ML, Bell CC, Berrettini W, et al. National Institutes of Health State-of-the-Science Conference Statement: Preventing Alzheimer disease and cognitive decline. Ann Intern Med. 2010;153(3):176-181.
  28. Gauthier S, Reisberg B, Zaudig M, et al. Mild cognitive impairment. Lancet. 2006;367(9518):1262-1270 [Review].
  29. Eschweiler GW, Layhe T, Klöppel S, et al. New developments in the diagnosis of dementia. Dtsch Arztebl Int. 2010;107(39):677-683 [Review].
  30. Gauthier S, Cummings J, Ballard C, et al. Management of behavioral problems in Alzheimer’s disease. Int Psychogeriatr. 2010;22(3):346-372 [Review].
  31. Alzheimer's Association. Stages of Alzheimer's. Available at http://www.alz.org/alzheimers_disease_stages_of_alzheimers.asp.
  32. Burton J. Dementia and delirium. Johns Hopkins Medicine. Available at http://www.hopkinsmedicine.org/gec/series/dementia.html.
  33. Inouye S. The Confusion Assessment Method (CAM): Training Manual and Coding Guide. Yale University School of Medicine; 2003. Also available at http://www.viha.ca/NR/rdonlyres/0AC07A64-FF24-41E3-BDC5-41CFE4E44F33/0/cam_training_pkg.pdf.
  34. Grace J, Cohn-Weiner D. Behavioral issues in Alzheimer’s disease. Med Health RI. 2002;85(7):213-215 [Review].
  35. Alzheimer’s Disease Education & Referral (ADEAR) Center. Alzheimer’s disease medications fact sheet. NIH Publication No. 08-3431; 2010.
  36. Qaseem A, Snow V, Cross JT Jr, et al. Current pharmacologic treatment of dementia: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians. Ann Intern Med. 2008;148(5):370-378.
  37. Alzheimer’s Association. Monitoring progression. Available at http://www.alz.org/professionals_and_researchers_monitoring_progression.asp.
  38. Alzheimer’s Association. Changing the trajectory of Alzheimer’s disease: a national imperative. 2010. Available at http://www.alz.org/documents_custom/trajectory.pdf.
  39. McGuinness B, Craig D, Bullock R, et al. Statins for the prevention of dementia. Cochrane Database Syst Rev. 2009;(2):CD003160.
  40. Price JF, Stewart MC, Deary IJ, et al. Low dose aspirin and cognitive function in middle aged to elderly adults: randomized controlled trial. BMJ. 2008;337:a1198.
  41. Arendash GW, Cao C. Caffeine and coffee as therapeutics against Alzheimer’s disease. J Alzheimers Dis. 2010;20 Suppl 1:S117-S126 [Review].
  42. Mangialasche F, Solomon A, Winblad B, et al. Alzheimer’s disease: clinical trials and drug development. Lancet Neurol. 2010;9(7):702-716 [Review].
  43. Morgan D. Immunotherapy for Alzheimer’s disease. J Intern Med. 2011;269(1):54-63 [Review].
  44. Alzheimer’s Association. Research Center: Treatment horizon. Available at http://www.alz.org/research/science/alzheimers_treatment_horizon.asp.
  45. Birks J, Grimley Evans J. Ginkgo biloba for cognitive impairment and dementia. Cochrane Database Syst Rev. 2009;(1): CD003120.
  46. Isaac MGEKN, Quinn R, Tabet N. Vitamin E for Alzheimer's disease and mild cognitive impairment. Cochrane Database Syst Rev. 2008;(3):CD002854.
  47. Spindler M, Beal MF, Henchcliffe C. Coenzyme Q10 effects in neurodegenerative disease. Neuropsychiatr Dis Treat. 2009;5:597-610.
  48. Pickering TG. Does Treating Hypertension Prevent Dementia? J Clin Hypertens. 2008;10(11):866-870.
  49. Gu Y, Nieves JW, Stern Y, et al. Food combination and Alzheimer disease risk: a protective diet. Arch Neurol. 2010;67(6):699-706.
  50. Gauthier S, Cummings J, Ballard C, et al. Management of behavioral problems in Alzheimer's disease. Int Psychogeriatr. 2010;22(3):346-372 [Review].
  51. Winslow BR, Onysko MK, Stob CH, et al. Treatment of Alzheimer Disease. Am Fam Physician. 2011;83(12):1403-1412.
Web sites accessed May 2011.

Copyright ©  American Academy of Family Physicians
Home | Privacy Policy | Contact Us | My Academy | Site Map
Members | Residents | Students | Patients | Media Center

AAFP Connection AAFP Connection | Facebook Find us on Facebook | Twitter Follow us on Twitter
RSS RSS | POD Podcasts

Read the Bulletin

Read Alzheimer's Disease Bulletin

Learning Objectives

Authors

References

CME Accreditation

Masthead

Drugs and Off-Label Uses